Indian Generics Firms Must Shift Gears For Third Wave, Says Lupin MD

Paths
MOVING BEYOND PLAIN GENERICS WILL BE CRITICAL SAYS LUPIN's MD, NILESH GUPTA

More from Strategy

More from Business